Microbiota and immunotherapyPublished on: 15 Apr 2019
AACR 2019: Fecal microbiota transplantation for anti-PD-1 therapy refractory melanoma
For patients with metastatic melanoma who fail to durably respond to PD-1 inhibitors, fecal microbiota transplantation (FMT) combined with reintroduction of anti-PD-1 therapy seems promising.
